Sfoglia per Autore
Myelofibrosis and following chronic myeloid leukemia: imatinib and ruxolitinib treatment in two cases
2013 A. Iurlo, D. Rapezzi, F. Binda, D. Cattaneo, A. Zaninoni, B. Fattizzo, U. Gianelli, A. Cortelezzi
Thrombotic events in myelofibrosis: relationship with clinical and morphological characteristics, JAK2V617F mutational status and autoimmune phenomena
2013 A. Iurlo, T. Radice, B. Fattizzo, F. Guidotti, P. Bianchi, E. Fermo, A. Zaninoni, D. Cattaneo, W. Barcellini, A. Cortelezzi
Oxidative status in essential thrombocythemia
2014 A. Iurlo, R. De Giuseppe, D. Cattaneo, C. Bucelli, N. Orofino, P. Bianchi, C. De Vita, D. Consonni, U. Gianelli, F. Bamonti, A. Cortelezzi
Diabetes mellitus and TKIS treatment in chronic myeloid leukemia
2014 A. Iurlo, E. Orsi, N. Orofino, D. Zimbalatti, D. Cattaneo, C. Bucelli, V. Resi, D. Consonni, A. Cortelezzi
Metabolic syndrome and TKIS treatment in chronic myeloid leukemia
2014 A. Iurlo, E. Orsi, C. Bucelli, N. Orofino, V. Resi, D. Zimbalatti, D. Cattaneo, D. Consonni, A. Cortelezzi
Three hematologic malignancies in the same patient : chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia
2014 B. Fattizzo, T. Radice, D. Cattaneo, M. Pomati, W. Barcellini, A. Iurlo
Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients
2014 A. Iurlo, A. Ubertis, S. Artuso, C. Bucelli, T. Radice, M. Zappa, D. Cattaneo, D. Mari, A. Cortelezzi
Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms
2014 U. Gianelli, A. Iurlo, D. Cattaneo, G. Lambertenghi-Deliliers
Imatinib and ruxolitinib association : first experience in two patients
2014 A. Iurlo, U. Gianelli, D. Rapezzi, D. Cattaneo, E. Fermo, F. Binda, E. Santambrogio, C. Bucelli, A. Cortelezzi
Type 1 vs type 2 calreticulin mutations and thrombotic risk in essential thrombocythemia patients: analysis of a monocentric series
2015 A. Iurlo, D. Cattaneo, S. Fabris, M. Sciumè, N. Orofino, F. Guidotti, G. Ciceri, D. Giannarelli, U. Gianelli, L. Gugliotta, A. Neri, A. Cortelezzi
Very eldery CP-CML patients treated with imatinib frontline: have concomitant therapies an impact on outcome and toxicity?
2015 A. Iurlo, R. Latagliata, C. Bucelli, D. Ferrero, F. Castagnetti, M. Breccia, E. Abruzzese, C. Fava, M. Annunziata, F. Stagno, P. Vigneri, M. Tiribelli, F. Cavazzini, G. Binotto, G. Mansueto, A. Gozzini, S. Russo, F. Falzetti, E. Montefusco, G. Gugliotta, D. Cattaneo, C.D. Djade, M. Cedrone, A. Russo Rossi, P. Avanzini, P. Pregno, E. Mauro, M. Endri, A. Spadea, F. Celesti, G. Giglio, A. Isidori, M. Crugnola, E. Calistri, F. Sorà, S. Sica, S. Storti, A. D’Addosio, G. Rege-Cambrin, L. Luciano, G. Saglio, G. Rosti, G. Alimena, A. Nobili, A. Cortelezzi
Cardiopulmonary exercise testing for early detection of pulmonary hypertension in primary myelofibrosis
2015 A. Iurlo, M. Sciumè, V. Mattiello, I. Cortinovis, N. Orofino, D. Cattaneo, A. Pierini, A. Cortelezzi
Primary hypereosinophilic sindromes and imatinib therapy: a rtrospective analysis of 38 cases
2015 N. Orofino, D. Cattaneo, T. Intermesoli, O. Spinelli, G. Reda, U. Gianelli, A. Beghini, A. Rambaldi, A. Cortelezzi, A. Iurlo
Imatinib discontinuation in chronic myeloid leukeia: a retrospective analysis on patients in clinical practice
2015 G. Rege-Cambrin, C. Fava, I. Dogliotti, P. Berchialla, E. Gottardi, M. Cerrano, D. Ferrero, M. Nicolosi, P. Pregno, E. Orlandi, D. Cattaneo, A. Iurlo, G. Catania, R. Davide, G. Saglio
Comprehensive Molecular Analyses in a Case of Masked Philadelphia Chronic Myeloid Leukemia
2015 D. Cattaneo, D. Morotti, C. Bucelli, M. Cannone, M. Zappa, S. Guerneri, A. Iurlo
Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis
2015 A. Iurlo, D. Cattaneo, U. Gianelli, E. Fermo, C. Augello, A. Cortelezzi
Transient elastography spleen stiffness measurements in primary myelofibrosis patients: a pilot study in a single centre
2015 A. Iurlo, D. Cattaneo, M. Giunta, U. Gianelli, D. Consonni, M. Fraquelli, N. Orofino, C. Bucelli, P. Bianchi, C. Augello, S. Bosari, M. Colombo, A. Cortelezzi
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib
2015 A. Iurlo, D. Cattaneo, L. Boiocchi, N. Orofino, E. Fermo, A. Cortelezzi, U. Gianelli
PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis
2015 C. Augello, U. Gianelli, R. Falcone, S. Tabano, F. Savi, E. Bonaparte, M. Ciboddo, L. Paganini, A. Parafioriti, D. Ricca, S. Lonati, D. Cattaneo, N. Fracchiolla, A. Iurlo, A. Cortelezzi, S. Bosari, M. Miozzo, S. Sirchia
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
2015 U. Gianelli, A. Iurlo, D. Cattaneo, A. Bossi, I. Cortinovis, C. Augello, A. Moro, F. Savi, R. Castelli, C. Brambilla, P. Bianchi, M. Primignani, A. Cortelezzi, S. Bosari
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile